We are Sorry, This Page doesn't Exist

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (MRNA) news f.....»»

The first set of immunogenicity data from the first trial of a potential vaccine to treat the coronavirus that causes COVID-19 could come as early as June, according to Evercore analyst Umer Ruffat. The National Institutes of Health.....»»

The clinical trial of the novel coronavirus (COVID-19) vaccine developed by Moderna Inc. (NASDAQ: MRNA) will start Monday, a government official confirmed to the Associated Press. read more.....»»

A coronavirus pandemic linkfest is for now a weekly feature here on Abnormal Returns. Please stay safe and find a vaccination site... VaccinesPfizer ($PFE) is seeking full FDA approval of its Covid vaccine. (politico.com)Moderna ($MRNA) sol.....»»

Moderna Inc. stock rose more than 1% in the extended session Wednesday after the biotechnology company said that a single-dose booster COVID-19 vaccine worked against the novel coronavirus' variants, according .....»»

Moderna Inc. stock rose more than 1% in the extended session Wednesday after the biotechnology company said that a single-dose booster COVID-19 vaccine worked against the novel coronavirus' variants, according .....»»

Six months after early trial participants got their second doses of the jab, Pfizer says the protection from its vaccine is strong and is holding up. A vial of Pfizer and BioNTech's coronavirus vaccine. CHRIS JACKSON/POOL/AFP.....»»

Shares of Johnson & Johnson gained 1.7% in premarket trading on Thursday, the day after a study published in the New England Journal of Medicine showed that its COVID-19 vaccine candidate generated neutral.....»»

A coronavirus pandemic linkfest is unfortunately now a weekly feature here on Abnormal Returns. You can read last week’s edition here. Please... ModernaHow Moderna's ($MRNA) vaccine works. (nytimes.com)Don't forget .....»»

The University of Oxford, which is partnering with large-cap pharma AstraZeneca plc (NYSE: AZN) to develop a vaccine for SARS-CoV-2, could lead the pack in advancing its vaccine cand read more.....»»

Moderna Inc (NASDAQ: MRNA), which is developing an mRNA vaccine codenamed mRNA-1273 for the coronavirus, announced an incremental update concerning its vaccine progra read more.....»»

Inovio Pharmaceuticals Inc (NASDAQ: INO) along with Moderna Inc (NASDAQ: MRNA) are front-runners among the companies developing vaccines for the SARS-CoV-2, th.....»»

Moderna Inc (NASDAQ: MRNA) reported Thursday ahead of the market open with a first-quarter loss that came in line with expectations and also issued an update on its coronavirus vaccine .....»»

Carl Recine/Reuters Moderna stock surged as much as 16% early Thursday after th.....»»

Moderna Inc (NASDAQ: MRNA) is a coronavirus vaccine play that has seen its shares rally close to 160% year-to-date. read more.....»»

Stocks traded sharply higher early Wednesday as reports that a drugmaker’s clinical trial for a treatment to help patients recover more quickly from the COVID-19 disease helped to offset a plunge in U.S. first-quarter gross domestic product.......»»

REUTERS/Tobias Schwarz Researchers are narrowing the focus of an ongoing trial of a potential coronavirus treatment after reviewing preliminary results.....»»

A key U.S. government trial of Gilead Sciences Inc's experimental coronavirus treatment may yield results as early as mid-May, according to the study's lead investigator, after doctors clamored to enroll their patients in the study......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

A coronavirus vaccine being developed by Oxford University will begin human trials as early as this Thursday, according to U.K. health secretary Matt Hancock......»»